Site is loading…
Vanderbilt University Medical Center-Vanderbilt Ingram Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37203.
Crixeo Clinical Trials Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.
Vanderbilt University Medical Center-Vanderbilt Ingram Cancer Center has participated in 6 clinical trials with 3 currently active.
Therapeutic areas: Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer, GVHD.
Sponsors: Gilead Sciences, Neovii Biotech, Merck Sharp & Dohme LLC.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Tennessee · View every site in Nashville
Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Vanderbilt University Medical Center-Vanderbilt Ingram Cancer Center has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Vanderbilt University Medical Center-Vanderbilt Ingram Cancer Center has 6 clinical trials on record, with 3 currently active. Their work covers Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer, GVHD.
Vanderbilt University Medical Center-Vanderbilt Ingram Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.